SELECTIVE PLATINATION OF BIOLOGICALLY RELEVANT POLYAMINES - LINEAR COORDINATING SPERMIDINE AND SPERMINE AS AMPLIFYING LINKERS IN DINUCLEAR PLATINUM COMPLEXES
H. Rauter et al., SELECTIVE PLATINATION OF BIOLOGICALLY RELEVANT POLYAMINES - LINEAR COORDINATING SPERMIDINE AND SPERMINE AS AMPLIFYING LINKERS IN DINUCLEAR PLATINUM COMPLEXES, Inorganic chemistry, 36(18), 1997, pp. 3919-3927
A new approach to the synthesis of novel bifunctional dinuclear platin
um complexes with linear coordinating spermidine and spermine is repor
ted. The synthetic pathway involves first the three-step selective pro
tection of the polyamines, giving bis(trifluoroacetyl)polyamines (1, 4
), (tert-butoxycarbonyl)bis(trifluoroacetyl) (2, 5), and (tert-butoxyc
arbonyl)polyamines (3, 6), respectively. The platination at desired si
tes with activated species of cis-or trans-[PtCl2(NH3)(2)] (CDDP or TD
DP,respectively) produces the BOG-protected dinuclear species [{cis-or
trans-PtCl(NH3)2)(2)}(2)(mu-L)]X (7, L = BOC-spermidine, X = (NO3)(0.
75)Cl-1.25; 9, L = (BOC)(2)-spermine, X = Cl-2; cis spermine species n
ot isolated). Through final deprotection, three different complexes we
re obtained and further investigated: trans-PtCl(NH3)(2)}(2){mu-spermi
dine-N-1,N-8}]Cl-3 (8), [{trans-PtCl(NH3)(2)}(2)- {mu-spermine-N-1,N-1
2}]Cl-4 (10), and [{cis-PtCl(NH3)(2)}(2){mu-spermine-N-1,N-12}]Cl-4 (1
1). One-and two-dimensional NMR solution studies provided evidence tha
t 11, at physiological pH, forms an inert bis((tetraamine)platinum) sp
ecies in which each Pt is chelated by a central and a terminal amino g
roup. In contrast, complexes 8 and 10 retain their reactivity, showing
only reversible formation of hydroxo bridges. The comparison of in vi
tro cytotoxicity data for 8, 10, and 11 with data for previously descr
ibed bifunctional dinuclear complexes shows the enhanced activity part
icularly of complex 8 in the CDDP-resistant L1210 cell line. The bindi
ng of 8 and 10 to poly(dG-dC).poly(dG-dC) is further increased and als
o reflected by B --> Z conformational changes at lower doses.